Aclaris Therapeutics, Inc.
Aclaris Therapeutics, Inc. (ACRS) — Form SCHEDULE 13G/A: Ownership over 5% (passive) (amendment)
About this filing
Aclaris Therapeutics, Inc. (ACRS) filed Form SCHEDULE 13G/A (ownership over 5% (passive) (amendment)) with the SEC on Nov 16, 2026. A Schedule 13G reports a passive investor owning more than 5% of the company.
Key facts
- Document
- —
More ACRS filings
- 8-K
Filed Nov 16, 2026
- 10-Q
Filed Nov 5, 2026
- 8-K
Filed Nov 5, 2026
- 8-K
Filed Oct 27, 2026
- 424B5
Filed Oct 27, 2026
- 8-K
Filed Oct 27, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.